Searchable abstracts of presentations at key conferences in endocrinology

ea0081p608 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Dysregulation of cytochrome P450 oxidoreductase (POR) in NAFLD and hepatocellular carcinoma; evidence from clinical, rodent and cellular models

da Conceicao Ismael , Nikolaou Nikolaos , Gathercole Laura , Harris Shelley , Dempster Niall , Moolla Ahmad , Hodson Leanne , Tomlinson Jeremy

The incidence of non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, continues to rise. NAFLD is associated with significant liver-specific and cardiovascular morbidity and mortality, including hepatocellular carcinoma (HCC). Currently, there are no licensed therapies, highlighting the importance of understanding the pathogenic mechanisms that drive the condition. Cytochrome p450 oxidoreductase (POR) plays an essential role in activa...

ea0050p318 | Obesity and Metabolism | SFEBES2017

5β-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver

Nikolaou Nikolaos , Gathercole Laura , Althari Sara , Green Charlotte , McNeil Catriona , Hughes Beverly , Arlt Wiebke , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic disease. Steroid hormones and bile acids are established regulators of metabolic phenotype. 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones and catalyzes a fundamental step in bile acid synthesis. We hypothesized that AKR1D1 plays a key role in hepatic metabolic homeostasis. Genetic manipulation of AKR1D1 ...

ea0050p318 | Obesity and Metabolism | SFEBES2017

5β-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver

Nikolaou Nikolaos , Gathercole Laura , Althari Sara , Green Charlotte , McNeil Catriona , Hughes Beverly , Arlt Wiebke , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic disease. Steroid hormones and bile acids are established regulators of metabolic phenotype. 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones and catalyzes a fundamental step in bile acid synthesis. We hypothesized that AKR1D1 plays a key role in hepatic metabolic homeostasis. Genetic manipulation of AKR1D1 ...

ea0063p647 | Interdisciplinary Endocrinology 1 | ECE2019

5-Beta-reductase (AKR1D1) deletion leads to increased insulin sensitivity in mature male mice

Arvaniti Anastasia , Harris Shelley , Nikolaou Nikolaos , Hazlehurst Jonathan , Moolla Ahmad , Dempster Niall , Cox Roger , Gathercole Laura , Tomlinson Jeremy

Bile acids (BA) are potent steroid hormones that mediate a variety of metabolic effects. They play a pivotal role in cholesterol catabolism, intestine nutrient absorption, and regulate lipid, glucose and energy metabolism. 5-Beta-Reductase (AKR1D1) is a key enzyme in the BA synthesis pathway, required for cholesterol metabolism into bile acids. We generated a novel global AKR1D1 knockout (KO) mouse which, as expected, has decreased total serum and hepatic BAs and altered BA co...

ea0049ep730 | Steroid metabolism + action | ECE2017

Gender specific metabolic phenotype in the 5β-reductase knockout mouse

Gathercole Laura , Klusonova Petra , Nikolaou Nikolaos , Hazlehurst Jonathan , Moolla Ahmad , Dempster Niall , Penning Trevor , Cox Roger , Odermatt Alex , Tomlinson Jeremy

Steroid hormones and bile acids are potent regulators of metabolism. The enzyme 5β-reductase (AKR1D1) has a crucial role in bile acid synthesis and also generates 5β-reduced dihydrosteroid metabolites, regulating intra-cellular steroid availability though the clearance of cortisol, testosterone, androstenedione, and progesterone. As AKR1D1 sits at the interface of bile acid synthesis and steroid metabolism, we have hypothesised that it plays a key role in metabolic h...

ea0041gp174 | Receptors & Signalling | ECE2016

5β-reductase (AKR1D1) is a regulator of glucose homeostasis in human hepatocytes and development of model systems to define its role in metabolic liver disease

Nikolaos Nikolaou , Dunford James , Green Charlotte , Lee Wenhwa , Lim Reina , Gathercole Laura , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. 5β-reductase (AKR1D1) is predominantly expressed in the liver and is a crucial regulator of steroid hormone clearance as well as bile acid synthesis. Its role in pathogenesis of metaboli...

ea0038p396 | Steroids | SFEBES2015

Model systems to define the role of AKR1D1 in metabolic liver disease

Nikolaou Nikolaos , Gathercole Laura , Dunford James , Lee Wenhwa , Lim Reina , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. It is tightly associated with obesity and type 2 diabetes, yet the precise mechanisms that drive its aetiology are not fully defined. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. AKR1D1 (5β-reductase), is predominantly expressed in...

ea0034p363 | Steroids | SFEBES2014

Androgen receptor over expression drives lipid accumulation in human hepatocytes

Nikolaou Nikolaos , Nasiri Maryam , Gathercole Laura , Castro Silvia Parajes , Krone Nils , Valsamakis George , Mastorakos George , Tomlinson Jeremy

Non-alcoholic fatty liver disease NAFLD has been associated with androgen deficiency, yet in the majority of patients with non-alcoholic steatohepatitis NASH, androgens levels are normal. In contrast, women with polycystic ovarian syndrome PCOS, which is characterised by androgen excess, have evidence of increased liver fat. Our hypothesis is that androgen exposure to the liver may be crucial in the amount of lipid that can accumulate in hepatocytes. C3A human hepatoma cells w...

ea0077p153 | Adrenal and Cardiovascular | SFEBES2021

Successful spontaneous pregnancy after transphenoidal surgery and bilateral adrenalectomy for Cushing’s disease: A case report

Shonibare Tolulope , Kyriakakis Nikolaos , Rajagopalan Chitra , Wiafe Eunice

Introduction: Cushing’s syndrome can impair the gonadotrophic axis in women of child bearing age if left untreated. Furthermore undergoing endoscopic transphenoidal surgery can render patients hypogonadal, thereby reducing the chances of spontaneous conception. In such cases, pregnancy is usually achieved by assisted contraceptive techniques. We present a case of spontaneous pregnancy following transphenoidal surgery and bilateral adrenalectomy.Case...

ea0078OC9.1 | Oral Communications 9 | BSPED2021

Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria?

Zilber Eva , Cramer Rebecca , Crowne Elizabeth , Ryan Fiona , Daskas Nikolaos

Background: Insulin tolerance test (ITT) is the gold-standard investigation in children with suspected growth hormone deficiency (GHD). Despite their benefits, ITTs are resource intensive, potentially dangerous and can result in unnecessary treatment due to false positive results in children that are at low risk for GHD.Methods: Retrospective analysis of all paediatric patients undergoing an ITT in two tertiary hospitals in the UK (centre A between 2017-...